| bibliographicCitation |
Naganuma M, Kobayashi T, Kunisaki R, Matsuoka K, Yamamoto S, Kawamoto A, Saito D, Nanki K, Narimatsu K, Shiga H, Esaki M, Yoshioka S, Kato S, Saruta M, Tanaka S, Yasutomi E, Yokoyama K, Moriya K, Tsuzuki Y, Ooi M, Fujiya M, Nakazawa A, Abe T, Hisamatsu T, Ogawa S, Tamura H, Uchida K, Fukui T, Fukata N, Nagahori M, Okamoto R, Miura M, Yoshimatsu Y, Hokari R, Kakuta Y, Fukuda T, Hojyo A, Sagami S, Hibi T, Sakata Y, Tsuruta K, Morita M, Mitsuyama K, Shibuya N, Miyazaki R, Hayashi R, Hiraoka S, Kobayashi K, Kajiwara M, Takagi T, Imaeda H, Tokunaga E, Ooi M, Ueno N, Tahara T, Yokoyama A, Murasugi S, Kuriyama T, Ohmori T, Takeuchi K, Hashimoto S, Hirayama D, Kazama T, Nakase H, Miyazaki T, Nakamura S, Oka A, Kawashima K, Ishihara S, Yanai S, Matsumoto T, Sato T, Yokoyama Y, Watanabe K, Yamamoto Y, Hiasa Y, Bamba H, Ando A, Ohta Y, Kanayama K, Kato J, Ohmiya N, Nanjyo S, . Real-world efficacy and safety of advanced therapies in hospitalized patients with ulcerative colitis. J Gastroenterol. 2023 Oct 13;58(12):1198–210. doi: 10.1007/s00535-023-02048-w. |